Open, observational, case-series study of the efficacy and tolerability of emu oil in the treatment of patients with psoriasis and xerotic eczema

Open, observational, case-series study of the efficacy and tolerability of emu oil in the treatment of patients with psoriasis and xerotic eczema
Carmen Ventura-Escuin

Objective

To study the therapeutic efficacy and tolerability of topical, twice-daily application of emu oil in the treatment of psoriasis and xerotic eczema.

Design

Open, observational, single-center study.

Center

Dermatology Service, Institut Universitari Dexeus USP, Barcelona, Spain.

Subjects

Twenty-seven patients of both sexes with a history of psoriasis or xerotic eczema were included.

Treatment

All patients received topical treatment with emu oil (Bálsamo de Emú. Bactinel®) on affected areas, twice daily for 30 days.

Main measurements

Pruritus, scaling, and erythema on affected areas were evaluated using a clinical evaluation scale from 0 to 3 (0=absent; 1=mild; 2=moderate; 3=severe).Adverse effects, tolerability and acceptability of the treatment were noted.

Results

Changes in the efficacy parameters evaluated were as follows: at 15 days of treatment, pruritus was reduced by 90% with respect to baseline evaluation, achieving complete remission (a reduction of 100%) at 30 days of treatment. Scaling was reduced by 60% at 15 days of treatment and by 80% at 30 days. Erythema was reduced by 30% at 15 days of treatment. Concerning tolerability, no adverse effects were noted during the study. The treatment was well tolerated by all the patients.

Conclusion

Topical treatment of psoriasis and xerotic eczema with emú oil significantly improved pruritus, scaling and erythema. The results showed a significant improvement as early as at 15 days of treatment, especially in pruritus. At 30 days, both pruritus and scaling showed complete resolution or a highly significant improvement, while erythema was moderately reduced. In the 27 patients studied, emu oil had beneficial effects on both psoriasis and xerotic eczema.

FROM: Piel Volume 20, Issue 8, October 2005, Pages 370–372

Information for the good of the many…